| Coronary Interventions and Diagnostics | Lifetime | 59 | ES 1 | 99.77 |
| Cardiac Imaging and Diagnostics | Lifetime | 171 | ES 2 | 99.69 |
| Cardiovascular Issues in Pregnancy | Lifetime | 42 | ES 1 | 99.37 |
| Peripheral Artery Disease Management | Lifetime | 82 | ES 2 | 99.20 |
| Cerebrovascular and Carotid Artery Diseases | Lifetime | 234 | ES 6 | 99.27 |
| Cardiac Valve Diseases and Treatments | Lifetime | 280 | ES 4 | 99.39 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 126 | ES 3 | 99.34 |
| Acute Myocardial Infarction Research | Lifetime | 196 | ES 3 | 99.37 |
| Cardiac Structural Anomalies and Repair | Lifetime | 271 | ES 3 | 99.14 |
| Health and Medical Research Impacts | Lifetime | 71 | ES 2 | 97.52 |
| Coronary Artery Anomalies | Lifetime | 149 | ES 1 | 98.41 |
| Aortic aneurysm repair treatments | Lifetime | 306 | ES 3 | 98.16 |
| Pharmaceutical industry and healthcare | Lifetime | 78 | ES 1 | 96.76 |
| Healthcare Systems and Technology | Lifetime | 196 | ES 3 | 96.41 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 77 | ES 2 | 95.63 |
| Cardiac Health and Mental Health | Lifetime | 535 | ES 7 | 96.63 |
| Aortic Thrombus and Embolism | Lifetime | 51 | ES 2 | 94.81 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 997 | ES 35 | 96.62 |
| Health and Medical Education | Lifetime | 351 | ES 109 | 94.30 |
| Kawasaki Disease and Coronary Complications | Lifetime | 329 | ES 3 | 93.60 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 891 | ES 19 | 93.18 |
| Meta-analysis and systematic reviews | Lifetime | 675 | ES 12 | 92.59 |
| scientometrics and bibliometrics research | Lifetime | 417 | ES 34 | 90.13 |
| Psychology Research and Bibliometrics | Lifetime | 399 | ES 220 | 87.17 |
| Academic Publishing and Open Access | Lifetime | 163 | ES 5 | 83.41 |
| Academic Writing and Publishing | Lifetime | 548 | ES 19 | 56.62 |
| Coronary Interventions and Diagnostics | 2021-2025 | 18 | ES 1 | 99.66 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 41 | ES 2 | 99.52 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 13 | ES 1 | 98.99 |
| Acute Myocardial Infarction Research | 2021-2025 | 78 | ES 3 | 98.57 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 70 | ES 1 | 97.79 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 153 | ES 6 | 97.78 |
| Cardiac Health and Mental Health | 2021-2025 | 92 | ES 2 | 96.13 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 336 | ES 17 | 97.75 |
| Peripheral Artery Disease Management | 2021-2025 | 145 | ES 1 | 95.31 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 19 | ES 4 | 95.01 |
| Cerebrovascular and Carotid Artery Diseases | 2021-2025 | 453 | ES 5 | 94.91 |
| Cardiac tumors and thrombi | 2021-2025 | 156 | ES 3 | 90.09 |
| Aortic aneurysm repair treatments | 2021-2025 | 501 | ES 6 | 91.03 |
| Coronary Artery Anomalies | 2021-2025 | 181 | ES 1 | 87.06 |
| Optical Coherence Tomography Applications | 2021-2025 | 729 | ES 16 | 79.15 |
| Health and Medical Research Impacts | 2021-2025 | 489 | ES 7 | 72.53 |
| Aortic Thrombus and Embolism | 2021-2025 | 105 | ES 7 | 56.84 |